We are live on ! Find out more
FCSC

Fibrocell Science Inc.
FCSC

Delisted

FCSC was delisted on the 12th of December, 2019.

43 hedge funds and large institutions have $103M invested in Fibrocell Science Inc. in 2013 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 20 increasing their positions, 7 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

186% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 7

5% more capital invested

Capital invested by funds: $98.1M → $103M (+$5.31M)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

2% less funds holding

Funds holding: 4443 (-1)

10% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 10

Holders
43
Holders Change
-1
Holders Change %
-2.27%
% of All Funds
1.25%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
9
Increased
20
Reduced
7
Closed
10
Calls
$1K
Puts
Net Calls
+$1K
Net Calls Change
-$101K
Name Holding Trade Value Shares
Change
Change in
Stake
TS
1
Third Security
Virginia
$57.7M +$14.2M +243,902 +35%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$14.6M
Jennison Associates
3
Jennison Associates
New York
$11.9M +$131K +2,248 +1%
MP
4
MSD Partners
New York
$7.25M
BFA
5
BlackRock Fund Advisors
California
$2.44M +$453K +7,790 +24%
Vanguard Group
6
Vanguard Group
Pennsylvania
$1.62M +$43.5K +748 +3%
BGA
7
Belmont Global Advisors
Texas
$1.01M +$970K +16,667 New
Northern Trust
8
Northern Trust
Illinois
$935K +$110K +1,886 +14%
BIT
9
BlackRock Institutional Trust
California
$833K +$106K +1,816 +15%
State Street
10
State Street
Massachusetts
$800K +$158K +2,712 +26%
Bank of New York Mellon
11
Bank of New York Mellon
New York
$655K +$73.9K +1,269 +13%
Citigroup
12
Citigroup
New York
$376K +$41K +704 +13%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$372K +$203K +3,496 +134%
SM
14
Sabby Management
Florida
$363K -$627K -10,766 -64%
TCIM
15
TIAA CREF Investment Management
New York
$339K +$19.5K +335 +6%
SC
16
Saiers Capital
New York
$287K
BIM
17
BlackRock Investment Management
Delaware
$243K +$52.3K +899 +29%
SIP
18
Stoneridge Investment Partners
Pennsylvania
$236K +$225K +3,867 New
Goldman Sachs
19
Goldman Sachs
New York
$170K -$162K -2,791 -50%
California State Teachers Retirement System (CalSTRS)
20
California State Teachers Retirement System (CalSTRS)
California
$164K +$39.2K +673 +33%
EEG
21
E.E. Geduld
$142K +$136K +2,333 New
TA
22
Teachers Advisors
New York
$120K +$10.8K +186 +10%
Charles Schwab
23
Charles Schwab
California
$98K
Janney Montgomery Scott
24
Janney Montgomery Scott
Pennsylvania
$92.4K -$757 -13 -0.8%
FSA
25
Franklin Street Advisors
North Carolina
$73K +$69.8K +1,200 New

FCSC Hedge Fund Activity: Q4 2013 in Review

43 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Fibrocell Science Inc. (FCSC) for Q4 2013, worth a combined $103M — up 5.4% from $98.1M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of FCSC and 9 opened new positions — a net loss of 1 holder — while 7 trimmed existing stakes and 20 added.

The largest buyer was Third Security, adding an estimated $14.2M. The largest seller was Barclays, cutting an estimated $1.28M.

  • 43 institutional investors held Fibrocell Science Inc. (FCSC) as of Q4 2013, down from 44 in Q3 2013.
  • Funds reported $103M of Fibrocell Science Inc. stock for Q4 2013, up 5.4% quarter-over-quarter.
  • 9 funds opened new Fibrocell Science Inc. positions in Q4 2013 and 10 closed out, a net change of -1 holder.
  • The largest Fibrocell Science Inc. buyer in Q4 2013 was Third Security, an estimated $14.2M added.
  • The largest Fibrocell Science Inc. seller in Q4 2013 was Barclays, an estimated $1.28M sold.

Based on aggregated 13F filings for Q4 2013.